Back
Speaker illustration

Doctor Max Waters

St. James's Hospital, Dublin (Ireland)

Presentations

Expected eligibility for PCSK9i therapy in secondary prevention, ESC/EAS guidelines vs Irish reimbursement criteria in post PCI patients

Event: ESC Congress 2023

Topic: Drug therapy

Session: Risk factors and prevention: lipids (3)

Access
Like
Thumbnail

Cost impact of the ESC/EAS 2019 dyslipidemia guidelines recommended use of PSCK9i in very-high-risk patients with an LDL <1.8mmol/L for secondary prevention

Event: ESC Congress 2023

Topic: Drug therapy

Session: Risk factors and prevention: lipids (2)

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources